ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 2,500.00
-95.00 (-3.66%)
At close: Jun 5, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 46.15 billion as of June 8, 2026. Its market cap has increased by 130.56% in one year.
Market Cap
46.15B
Enterprise Value
52.91B
Revenue
12.51B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,500.00
Market Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 46.15B, an increase of 82.08%. That is a compound annual growth rate of 9.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 49.20B | 48.14% |
| Dec 30, 2025 | 33.21B | 74.69% |
| Dec 30, 2024 | 19.01B | -36.49% |
| Dec 28, 2023 | 29.93B | -2.53% |
| Dec 29, 2022 | 30.71B | -31.89% |
| Dec 30, 2021 | 45.09B | 20.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PanGen Biotech | 67.98B |
| EyeGene | 63.98B |
| Progen | 62.27B |
| IMGT Co.,Ltd. | 62.02B |
| Aptamer Sciences | 54.39B |
| Psomagen | 52.71B |
| Quratis | 51.41B |
| Shaperon | 50.40B |